A new treatment to reduce inflammation after ischemic stroke
A New Anti-inflammatory Therapy for Ischemic Stroke
This study is testing a new treatment to help reduce inflammation after a stroke, which could lead to better recovery for patients, and it’s being developed with the help of top universities to ensure it’s safe and effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornovus Pharmaceuticals, INC. NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10812579 on NIH RePORTER |
What this research studies
This research focuses on developing a novel anti-inflammatory therapy aimed at improving outcomes for patients who have experienced an ischemic stroke. The approach involves blocking immune cell-mediated inflammation, which is a significant contributor to the damage caused by strokes. The researchers have identified a promising drug candidate and are conducting studies to assess its safety and effectiveness. Collaborations with academic institutions enhance the research's credibility and potential for success.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently suffered an ischemic stroke and are experiencing inflammation-related complications.
Not a fit: Patients who have not had an ischemic stroke or those with other types of strokes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment that significantly improves recovery and reduces complications for ischemic stroke patients.
How similar studies have performed: Previous research has shown promise in using anti-inflammatory approaches for stroke treatment, indicating that this strategy could be effective.
Where this research is happening
New Haven, United States
- Cornovus Pharmaceuticals, INC. — New Haven, United States (Active)
Researchers
- Principal investigator: Liang, Bruce — Cornovus Pharmaceuticals, INC.
- Study coordinator: Liang, Bruce
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.